Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles
about
Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41Structure-Based Design of a Protein Immunogen that Displays an HIV-1 gp41 Neutralizing EpitopeA gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen RecognitionStructure of an HIV-1-neutralizing antibody target, the lipid-bound gp41 envelope membrane proximal region trimerComparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vectorBroad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitopeProlonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitutionInduction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccinesRational antibody-based HIV-1 vaccine design: current approaches and future directionsHIV-1 Env-specific memory and germinal center B cells in C57BL/6 miceThe stem of vesicular stomatitis virus G can be replaced with the HIV-1 Env membrane-proximal external region without loss of G function or membrane-proximal external region antigenic properties.Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNAInitial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadthStructure-based vaccine design in HIV: blind men and the elephant?The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralizationImmunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein.Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.Forced virus evolution reveals functional crosstalk between the disulfide bonded region and membrane proximal ectodomain region of HIV-1 gp41Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralizationThe broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5.HIV-1 envelope glycoprotein trimers display open quaternary conformation when bound to the gp41 membrane-proximal external-region-directed broadly neutralizing antibody Z13e1Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10.Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies.Prospects for prophylactic hepatitis C vaccines based on virus-like particlesHepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice.Limitations to the structure-based design of HIV-1 vaccine immunogens.Multiple antigen peptide mimetics containing gp41 membrane-proximal external region elicit broad neutralizing antibodies against human immunodeficiency virus type 1 in guinea pigs.Hepatitis B virus surface antigen assembly function persists when entire transmembrane domains 1 and 3 are replaced by a heterologous transmembrane sequence.Live attenuated rubella viral vectors stably express HIV and SIV vaccine antigens while reaching high titers.The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects.DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity.
P2860
Q27312171-B2F095CC-00CB-4396-BAC3-1CCD661ECA5EQ27675260-1F40D85B-77EA-4A31-B0C6-1837F0B626F6Q27676864-4033C170-B058-496B-B977-6DF1129D9648Q27681501-2D780B16-A7C7-43E0-980F-73FD48ABEB9CQ28533970-7A227867-673A-491E-A1BE-A5CD514CCCA1Q33417195-FB00EE61-1213-4B50-A2EF-8FE5FE89EC28Q33778466-302378A0-B4B9-4D83-A114-39CB6520FA4FQ33916676-D5B91BAE-8771-4AC5-BC82-211652B01C7DQ33937285-12A44A68-D92B-497F-AA27-E7B0D5D8E601Q34303547-8E8ED649-D526-4241-9887-54BAAEA37F08Q34399656-427CB781-5ADC-4D75-8CB2-9AE21C8DA7D5Q34712503-DEB69199-5F97-4B5C-AF9A-9F2E6B53A472Q34848486-A01DBE58-5298-4EA5-96EE-66FFCD3DA65AQ34937404-BCD27A60-4F45-4DFF-A047-D50BCB41CFAAQ34987048-F1B4ACF6-4AF2-4BFB-8126-A15FC8304145Q35644971-E66E08F5-82F4-4D73-A642-410A2E08D1ADQ35667479-D68282D8-3D20-4A6B-BCDF-23836A2C5598Q36281860-C1640B20-07E0-4E26-AB2E-38893E203BDBQ36814871-C96504CD-EBD3-408B-A572-F658C0DF883AQ36837815-38212ED5-5F7F-4DE8-A085-BD23AC263754Q36898696-F256C346-BAF8-409C-BE49-E0E74597E127Q36911710-CE1885F0-4232-4F86-A664-16A9D5E95C92Q36974754-9CC2DC01-EE4A-4EA4-9D41-BAB792EA1F9AQ37183108-B36D5577-31B4-4DD8-AB7B-B8A7432945F0Q37438127-0DB90181-EAB9-4E2B-BF69-F42F7F004A9DQ37505405-6F444F0C-510E-4463-93DD-E7754E216901Q37845082-D9900B7C-3FEC-4EF0-AECF-31C0038F31FEQ37910841-C794967E-0C38-4909-B8C8-834961592CD1Q39136039-6E525187-ADD6-4120-AD23-880AE649C85EQ39617158-E8184335-B114-4D52-ACEE-844506D90674Q42284964-C106F330-644D-432B-A1F1-ED590032FFD8Q52581587-D556A511-84E2-450F-81C9-46FD49B81971Q52729536-D2C663F0-54FB-4491-8EF3-61CF6177B99A
P2860
Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Analysis of the human immunode ...... is B surface antigen particles
@en
Analysis of the human immunode ...... s B surface antigen particles.
@nl
type
label
Analysis of the human immunode ...... is B surface antigen particles
@en
Analysis of the human immunode ...... s B surface antigen particles.
@nl
prefLabel
Analysis of the human immunode ...... is B surface antigen particles
@en
Analysis of the human immunode ...... s B surface antigen particles.
@nl
P2093
P2860
P1433
P1476
Analysis of the human immunode ...... is B surface antigen particles
@en
P2093
A Spadaccini
I Berkower
P2860
P356
10.1016/J.VIROL.2007.11.005
P407
P577
2007-12-26T00:00:00Z